作者:
Woll,P.J. [1]
;
Reichardt,P. [2]
;
LeCesne,A. [3]
;
Bonvalot,S. [4]
;
Azzarelli,A. [5]
;
Hoekstra,H.J. [6]
;
Leahy,M. [7]
;
VanCoevorden,F. [8]
;
Verweij,J. [9]
;
Hogendoorn,P.C.W. [10]
;
Ouali,M. [11]
;
Marreaud,S. [12]
;
Bramwell,V.H.C. ;
Hohenberger,P.
作者单位:
Institut Gustave Roussy, Villejuif, France
[1]
National Cancer Institute, Milan, Italy
[2]
NCIC Clinical Trials Group, Kingston, ON, Canada
[3]
Netherlands Cancer Institute, Amsterdam, Netherlands
[4]
European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium
[5]
Christie Hospital, Manchester, United Kingdom
[6]
Robert Roessle Hospital and Tumour Institute, Charité Campus Berlin Buch, Berlin, Germany, HELIOS
[7]
Leiden University Medical Centre, Leiden, Netherlands
[8]
University of Sheffield, Sheffield, United Kingdom
[9]
Erasmus University Medical Center, Daniel van Hoed Cancer Centre, Rotterdam, Netherlands
[10]
Robert Roessle Hospital and Tumour Institute, Charité Campus Berlin Buch, Berlin, Germany, Mannheim
[11]
University of Groningen Medical Centre, Groningen, Netherlands
[12]
发布时间
2013-11-20